SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): December 28, 1998
STRYKER CORPORATION
(Exact name of registrant as specified in charter)
MICHIGAN 0-9165 38-1239739
(State or other (Commission (IRS employer
jurisdiction of file number) identification no.)
incorporation)
P.O. Box 4085, 49003-4085
Kalamazoo, Michigan (Zip Code)
(Address of principal
executive offices)
(616) 385-2600
(Registrant's telephone number, including area code)
ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS.
On December 28, 1998 and January 5, 1999, Stryker
Corporation (the "Company") issued an aggregate of 229,801 shares
of its Common Stock, $.10 par value, to certain non-United States
persons in exchange for an equivalent number of shares of
Matsumoto Medical Instruments, Inc., a corporation organized
under the laws of Japan that was 76.8% owned by the Company prior
to such transactions ("MMII"), in an offshore transaction
pursuant to Regulation S promulgated under the Securities Act of
1933, as amended. An additional 35,465 shares of MMII stock were
purchased from certain of such persons for cash on December 28,
1998. As a result of these transactions, the Company's ownership
percentage of MMII increased to 92.4%. No underwriter or
placement agent was used in connection with these transactions.
SIGNATURES
Pursuant to the requirements of the Securities and
Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly
authorized.
Date: January 11, 1999
STRYKER CORPORATION
By: /s/ David J. Simpson
David J. Simpson
Vice President, Chief
Financial Officer and
Secretary
